GeneThera, Inc. is a biotechnology company that focuses on eradicating zoonotic diseases such as COVID-19 (Novel Coronavirus), Paratuberculosis (Johne’s disease), Mad Cow Disease, Chronic Wasting Disease, and E.coli and Salmonella infections by applying proprietary molecular sciences and technologies. The firm is working on novel molecular diagnostic tests, therapeutics, and vaccine solutions through robotic technologies to meet the demands of the veterinary, agriculture, and healthcare industries. The company was founded by Antonio Milici in November 1998 and is headquartered in Westminster, CO.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company